Bifidobacterium lactis is one of the most widely used probiotic bacteria in the world, found in yogurts, supplements, and infant formulas. It’s a friendly gut bacterium that naturally lives in the human intestine and has been studied for its effects on digestion, immune function, and gut barrier health. On supplement labels, you may also see it listed as Bifidobacterium animalis subsp. lactis, which is its full scientific name.
The Name Can Be Confusing
Bifidobacterium lactis was originally described as its own species in 1997. A few years later, genetic analysis revealed it was so closely related to another species, Bifidobacterium animalis, that scientists reclassified it in 2004 as a subspecies: Bifidobacterium animalis subsp. lactis. In practice, most supplement companies and food manufacturers still use the shorter “Bifidobacterium lactis” or “B. lactis” because it’s simpler and more recognizable. Both names refer to the same organism.
Within this subspecies, several commercial strains have been developed for different health applications. The most commonly studied are BB-12 and HN019. Each strain has its own body of clinical research, so the specific strain listed on a product label matters more than just seeing “B. lactis” on the ingredient list.
How It Supports Digestion
The best-studied benefit of B. lactis is its effect on sluggish digestion. In people who have fewer than three bowel movements per week, supplementation with the HN019 strain has shown meaningful improvements. A double-blind, placebo-controlled trial found that people with low stool frequency who took HN019 gained about two additional bowel movements per week at the higher dose, compared to less than one additional movement in the placebo group. The same study found that straining during bowel movements decreased significantly in the group taking the higher dose.
That said, the results aren’t dramatic across the board. In the broader study population (including people who weren’t particularly constipated), the probiotic didn’t outperform placebo on the primary measure of colon transit time. The benefits appear most relevant for people who are genuinely struggling with infrequent bowel movements rather than those with normal digestion looking for a boost. A separate fermented oat product containing the BB-12 strain has also been observed to help normalize bowel function in older adults.
Effects on the Immune System
B. lactis has shown some ability to support immune defenses against common respiratory infections. A clinical study of healthy, physically active adults found that supplementation with the Bl-04 strain reduced the risk of upper respiratory tract infections by 27% over a five-month winter season. In a separate challenge study where participants were deliberately exposed to a respiratory virus, those who had taken Bl-04 for a month beforehand showed lower levels of virus in their nasal passages compared to placebo.
Lab research has begun to explain why. When cells were exposed to B. lactis alongside a low level of virus, the bacteria appeared to mildly inhibit viral replication. This effect didn’t hold up against higher viral loads, suggesting the probiotic works best as a supporting player in immune defense rather than a standalone antiviral.
Strengthening the Gut Lining
Your intestinal lining is a single layer of cells held together by protein structures that act like seals between them. When these seals weaken, the gut becomes “leaky,” allowing bacteria and inflammatory molecules to slip into the bloodstream. B. lactis and related Bifidobacterium species help maintain this barrier by restoring the proteins that keep those cellular seals tight.
In lab and animal studies, various Bifidobacterium strains have been shown to increase levels of key barrier proteins after they’ve been damaged by inflammation. They also suppress the production of inflammatory signals that weaken the gut lining in the first place. Research in mice fed a high-fat diet found that the LKM512 strain of B. lactis reduced fat accumulation in the liver, calmed inflammation in fat tissue, and improved the gut barrier. These changes were linked to better insulin sensitivity, pointing to a connection between gut barrier health and metabolic function.
Surviving the Trip to Your Gut
One challenge with any oral probiotic is making it past stomach acid alive. In a simulated digestive system, only about 5% of unprotected bifidobacteria survived the stomach, and just 2% made it through the full gastrointestinal tract. That’s a steep drop, but it helps explain why formulation matters so much.
When the same bacteria were placed in specially coated tablets, stomach survival jumped to over 70%, a roughly 13-fold increase. Even a basic uncoated tablet improved gastric survival to around 31%. This is why the format of a probiotic product (capsule type, coating, whether it requires refrigeration) can be just as important as the CFU count on the label. A product with 10 billion CFU in unprotected powder form may deliver fewer live bacteria to your intestine than a well-formulated product with a lower count.
Typical Doses in Research
Clinical trials have generally used B. lactis at doses ranging from 1 billion to 10 billion CFU per day. The BB-12 strain showed digestive benefits at around 1 billion CFU daily over four weeks, while HN019 trials have used approximately 5 to 7 billion CFU per day. Higher doses don’t always produce better results. In the constipation trial, both the high and low doses of HN019 improved bowel movement frequency by similar amounts in people with low stool frequency.
Where You’ll Find It
B. lactis is added to many commercially available yogurts, fermented milks, and kefir products. It doesn’t typically occur naturally in these foods the way traditional yogurt cultures do. Instead, manufacturers add it during production. You’ll also find it in probiotic supplements (capsules, powders, chewables) and in some infant formulas. Checking the label for a specific strain designation like BB-12, HN019, or Bl-04, rather than just the species name, gives you a better sense of what the product has actually been tested for.
Safety Profile
B. lactis has a strong safety record. The FDA has accepted GRAS (Generally Recognized as Safe) status for specific strains under their intended conditions of use, meaning the agency had no questions about the safety conclusions presented by manufacturers. Side effects in clinical trials are generally minimal and comparable to placebo.
One caution: the bacteria are sometimes grown using milk during fermentation, which means the final product can contain milk-derived protein. If you have a milk allergy, check labels carefully. There is also a theoretical risk of opportunistic infection in people with severely compromised immune systems, though this is not considered a concern for the general population under normal use conditions.